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CD1 molecules function to present lipid-based
antigens to T cells. Here we present the crystal struc-
ture of CD1c at 2.5 A˚ resolution, in complex with
the pathogenic Mycobacterium tuberculosis antigen
mannosyl-b1-phosphomycoketide (MPM). CD1c
accommodated MPM’s methylated alkyl chain ex-
clusively in the A0 pocket, aided by a unique exit
portal underneath the a1 helix. Most striking was an
open F0 pocket architecture lacking the closed cavity
structure of other CD1 molecules, reminiscent of
peptide binding grooves of classical major histocom-
patibility complexmolecules. This feature, combined
with tryptophan-fluorescence quenching during
loading of a dodecameric lipopeptide antigen, pro-
vides a compelling model by which both the lipid
and peptide moieties of the lipopeptide are involved
in CD1c presentation of lipopeptides.
INTRODUCTION
CD1 molecules are major histocompatibility complex (MHC)-like
proteins that are broadly expressed on antigen-presenting cells
(APCs) and serve to present lipid-based antigens to T cells in the
vertebrate immune response. Unlike the polymorphic, peptide-
presenting, classical class I and II MHCmolecules, CD1 proteins
exhibit essentially no allelic variation, and in humans their genes
are located outside of the chromosome 6 MHC region on chro-
mosome 1 at 1q22-23 (Albertson et al., 1988). There exist five
human isoforms of CD1 that are grouped according to their
amino acid homology, genomic organization, and immunological
function: CD1a, CD1b, and CD1c form Group 1 (Calabi et al.,
1989), CD1d forms Group 2, and CD1e has been proposed toIform a third group because of its intracellular chaperone function
(Angenieux et al., 2000; de la Salle et al., 2005). Tyrosine-con-
taining motifs present in the cytoplasmic tail of CD1b, CD1c,
and CD1d molecules determine where they are trafficked within
the cell, and thus to what repertoire of lipid-based antigens they
may be exposed. The trafficking route as well as structural
features unique to each CD1 molecule endow them with the
ability to bind a structurally diverse array of lipid antigens from
bacterial (Willcox et al., 2007) and endogenous (De Libero and
Mori, 2007) sources and present these to T cells at the cell
surface (Sullivan and Kronenberg, 2007).
CD1 molecules have evolved a deep and narrow binding
cavity that is well suited to anchoring the hydrophobic alkyl
chains of lipid molecules. Based on the structures of CD1a
(Zajonc et al., 2005b, 2003), CD1b (Batuwangala et al., 2004;
Gadola et al., 2002), and mouse (Wu et al., 2006; Zajonc et al.,
2005a, 2005c, 2008; Zeng et al., 1997) and human (Koch et al.,
2005) CD1d, the binding cavity contains two major pockets,
A0 and F0. In each of these structures, the A0 pocket extends
deep into the CD1 molecule and is enclosed by the A0 roof.
Variation in the A0 pocket size, the shape of the F0 pocket, along
with the presence of an exit portal (C0) and T0 tunnel unique to
CD1b explain each isoform’s ability to bind different classes of
lipids, varying in the length and saturation of their hydrocarbon
tails and the chemical nature of their head group.
Of the CD1 isoforms, CD1c is unique in its ability to present
mycobacterial phosphoketides (de Jong et al., 2007; Matsunaga
et al., 2004) and polyisoprenoids (Moody et al., 2000) containing
branched alkyl chains and has also been shown to present
lipopeptides with a long peptide moiety similar in length to those
presented by MHC class II molecules (Moody et al., 2004; Van
Rhijn et al., 2009). CD1c is expressed at high amounts on B cells,
myeloid dendritic cells (DCs), and thymocytes (Dougan et al.,
2007) and intracellularly it broadly surveys the endocytic system
(Sugita et al., 2000), particularly early and late endosomes (Briken
et al., 2002, 2000) similar to the path of MHC class II proteins.mmunity 33, 853–862, December 22, 2010 ª2010 Elsevier Inc. 853
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Three-Dimensional Structure of CD1c Presenting MPMCD1c is theonlyCD1 isoform that hasbeenshown to interactwith
both ab (Beckman et al., 1996; Porcelli et al., 1989; Van Rhijn
et al., 2009) and gd (Spada et al., 2000) T cells to date.
Functionally, CD1c has a clear role in mediating T cell
responses to infectious pathogens, in particularMycobacterium
tuberculosis, the causative agent of tuberculosis (Beckman
et al., 1996; Moody et al., 2000; Ulrichs et al., 2003). This was
further elucidated through elegant studies of CD1c presentation
of synthetic forms of mannosyl phosphodolichols (MPDs) and
mannosyl-b1-phosphomycoketides (MPMs) identical to those
present in minute quantities in the cell walls of M. tuberculosis
and M. avium (de Jong et al., 2007; Moody et al., 2000). T cell-
specific, CD1c-presented MPMs contain structurally distinct
single alkyl chains ranging from C30-34 that have stereo-specific
(S) methyl branches starting at C4, repeated on every fourth
carbon thereafter (de Jong et al., 2007). Made by polyketide
synthase 12 (pks12) (Matsunaga et al., 2004), an enzyme that
appears to be unique to mycobacteria, the methyl branches of
MPM represent an unusual pathogen-associated molecular
pattern that, when presented at even minute amounts by
CD1c, can potently activate a T cell response.
The molecular features of CD1c that enable it to bind and
present the structurally divergent MPM and 12-mer lipopeptide
antigens have remained unclear. Computational modeling and
molecular dynamics simulations have provided hints of divergent
features of CD1c (Garzon et al., 2009); however, an experimen-
tally derived three-dimensional structure has evaded determina-
tion. Our 2.5 A˚ crystal structure of CD1c in complex with
a synthetic, all-S, C32 mannosyl-b1-phosphomycoketide
(MPM) demonstrates how CD1c accommodates the unique
methyl-branched structure of mycoketides and reveals an
open F0 groove feature that may explain CD1c’s ability to bind
and present dodecameric lipopeptides (lipo-12).
RESULTS
Crystallization and Structure Determination
of CD1c in Complex with MPM
Recombinant expression of CD1c was performed via the bacu-
lovirus insect expression system. An initial, expression-opti-
mized construct was designed by fusing the b2microglobulin
(b2m) subunit covalently to theN terminus of CD1c via a 15 amino
acid glycine-serine linker. Repeated attempts to crystallize this
construct failed, so a crystal contact-optimized construct was
further generated by swapping the CD1c a3 domain for that of
the a3 domain of CD1b. Additional mutations were made to
stabilize the interface between the platform and a3 domain,
reduce the heterogeneity of glycosylation (four of the five
putative N-linked glycosylation sites were eliminated), and facil-
itate crystal packing (see Supplemental Experimental Proce-
dures available online). Several methods were used to establish
that the CD1c a1 and a2 platform domain in this optimized
mutant was functionally and structurally conserved in relation
to wild-type CD1c. CD spectra of wild-type and optimized
CD1c were superimposable (Figure 1A), demonstrating overall
secondary structure similarity between the two proteins.
Furthermore, size-exclusion chromatography and native poly-
acrylamide gel shift demonstrated similar binding of the CD1c-
specific F10/21A3 and L161 antibodies to both wild-type and854 Immunity 33, 853–862, December 22, 2010 ª2010 Elsevier Inc.optimized CD1c (Figures 1B and 1C), confirming that the three-
dimensional epitopes of these antibodies on these two CD1c
constructs was conserved. To assess the functional conserva-
tion of our optimized CD1c construct, we performed lipid loading
assays based on isoelectric focusing (IEF) gel-shift similar to
those described by Zhou et al. (2004) and confirmed that lipid
binding was not compromised by the modifications made to
CD1c to facilitate crystallization (Figure 1D). Furthermore,
optimized CD1c loaded with our synthetic MPM was able to
stimulate the CD8-1 T cell line, which is specific for CD1c
presenting MPM, at equivalent amounts to that of native CD1c
presentingMPM (Figure 1E), confirming the functional conserva-
tion of these two constructs.
Chemically synthesized mannosyl-b1-phosphomycoketide
(MPM) was passively loaded into recombinant, optimized
CD1c, and the resulting complex was purified by gel filtration
chromatography. The complex of CD1c and MPM was crystal-
lized and the structure was determined via molecular replace-
ment with CD1b as the initial model. There was one complex
of CD1c and MPM in the asymmetric unit. The structure was
refined to 2.5 A˚ with a final Rcryst and Rfree of 24.0% and
27.3%, respectively, and 93.3% of the residues in the most
favored region of the Ramachandran plot (Figure 2 and Table 1).
A loop connecting the a1 helix to the b sheet was poorly resolved
in the electron density and residues Q87-Y89 were excluded
from the final model as a result. Furthermore, only the first four
amino acids of the glycine and serine linker engineered to fuse
b2m and the CD1c heavy chain were resolved in the electron
density. Amino acid side chains with weak or absent electron
density had their occupancies set to zero.
Examination of crystallographic symmetry mates revealed
that the crystal packing mutation (K108G) engineered into the
CD1copt construct was critical to the establishment of a key
crystal contact with a loop (residues 261 to 276) in the a3 domain
of a symmetry mate. The presence of a large charged side chain
at position 108 would create a steric clash and disrupt a crystal
contact at this location.
Structural Topology of the CD1c Binding Groove:
Conserved Features
The CD1c heavy chain is composed of a1, a2, and a3 domains
that assemble noncovalently with the b2m subunit, similar to
other CD1 family members. The a1 and a2 domains constituted
the ligand-binding platform domain and have the canonical MHC
structure of two a helices supported by a six-stranded b sheet
(Figures 2A and 2B). This architecture supported the formation
of two distinct ligand-binding cavities, lined with hydrophobic
residues that are compatible with the binding of hydrophobic
alkyl chains characteristic of lipid molecules. These two cavities
have been namedA0 and F0 based on homology with the peptide-
binding pockets of MHC class I molecules and consistent with
the pocket nomenclature for other CD1 family members
(Zeng et al., 1997). The platform domain (a1 and a2 domains)
of CD1c was most structurally related to that of CD1b based
on a backbone rmsd of 1.16 A˚ (in comparison to CD1a [1.50 A˚]
and CD1d [1.60 A˚]), consistent with CD1c’s close (59%) amino
acid identity to CD1b (Figure S1).
CD1c’s A0 pocket had the shape of a wide circular tunnel with
one area of constriction, located slightly underneath the
Figure 1. The a1 and a2 Platform Domains of CD1c and Optimized CD1c Are Structurally and Functionally Conserved
(A) CD spectra of CD1c and optimized CD1c (CD1copt) at 20
C and 95C.
(B) The CD1c and CD1copt constructs both bind the F10/21A3 single-chain antibody as assessed by size exclusion chromatography. SDS-PAGE analysis of the
shifted peak fractions confirms the presence of complexes between both CD1c and CD1copt with F10/21A3.
(C) Both CD1c and CD1copt bind to the CD1c-specific monoclonal antibody L161 (lanes 2 and 4, respectively) as evidenced by native gel shift compared to L161,
CD1c, or CD1copt alone (lanes 1, 3, and 5, respectively).
(D) Loading efficiency of a variety of lipids is conserved betweenCD1c andCD1copt: CD1c or a fully glycosylated version of CD1copt are shown on a native isoelec-
tric focusing gels as unloaded or loaded with the charged lipid GT1b (left). Addition of saposins and a series of lipids resulted in similar shifting of the CD1c-GT1b
andCD1copt-GT1b complexes upon displacement of GT1b (right). Shown are: lactosylceramide (LC), PBS57, sulfatide, GM3, orGSL-1 and the indicated saposin.
(E) CD1c-restricted T cell recognition of wild- type and optimized CD1c molecules. Wild-type and CD1copt proteins were coated on a microtiter plate and pulsed
with the indicated concentrations of synthetic MPM lipid (filled symbols), then washed and used to stimulate IFN-g release by the CD8-1 T cell line. Open symbols
show CD8-1 T cell responses to wild-type and CD1copt molecules that were pulsed with vehicle alone. Shown are the means and standard deviations of IFN-g
concentrations from three replicates, as quantified by a standardized ELISA.
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Three-Dimensional Structure of CD1c Presenting MPMA0 portal, where the A0 pocket opened to solvent (Figure 3, top).
This constriction selected for a clockwise directionality for lipid
binding in the A0 pocket, specifically for those lipids with methyl-
ated branches, as seen in MPM. CD1c’s circular A0 pocket was
centered around the A0 pole formed by the van derWaals contact
of V12 and F70. The A0 pole as well as the A0 roof, composed of
residues L66, L162, and T166, made up the conserved features
of the A0 pocket found in other CD1 isoforms (Figure 3). The A0
portal is rimmed with the hydrophobic residues L69, F72, Y73,Iand V155 and the polar T158; it is here where the phosphoman-
nose head group of MPM was situated, in a conformation
consistent with presentation to a T cell receptor (TCR) (Figure 2).
The A0 portal was continuous with the F0 pocket, lacking
a dividing wall between these two cavities (Figure 2A, bottom).
In comparison to the other human CD1 isoforms, CD1c had
the second largest cavity volume, 1780 A˚3, compared with
CD1b (2200 A˚3), CD1d (1650 A˚3), and CD1a (1280 A˚3) as calcu-
lated by the program Pocket-Finder (Hendlich et al., 1997).mmunity 33, 853–862, December 22, 2010 ª2010 Elsevier Inc. 855
Figure 2. Structure of CD1c in Complex with MPM and a C12 Spacer
Lipid
(A) Top view of the ligand binding domain as a ribbon (top) and surface (bottom)
diagram. The CD1c heavy chain is shown in light magenta, MPM in yellow, and
C12 in light green.MPM is bound in the A
0 pocket and aC12 is bound in the open
F0 groove. Two ordered water molecules that solvate the MPM head group are
shown as purple spheres. Omit map (green) and 2Fo-Fc (white) densities at
a s = 1 and 1.4, respectively, are shown for both ligands.
(B) Side view of CD1c shown as a ribbon diagramwith b2m colored light purple.
The alkyl chain of MPM is buried underneath the a1 helix, with its phospho-
mannose head group reaching out of the ligand-binding groove, accessible
for recognition by a TCR. The chemical structures of MPM and C12 are shown
in the bottom panel.
Table 1. Data Collection and Refinement Statistics, Molecular
Replacement
Data Collection
Space group P212121
Cell dimensions
a, b, c (A˚) 53.72, 87.09, 88.81
a, b, g () 90, 90, 90
Resolution (A˚) 43.5-2.5 (2.54-2.50)
Rmerge 8.2 (52.1)
I/sI 19.5 (1.9)
Completeness (%) 96.1 (76.6)
Redundancy 5.4 (2.3)
Refinement
Resolution (A˚) 43.5–2.5
No. reflections 14,397
Rwork/Rfree 24.0/27.3
No. atoms
Protein 3,014
Lipid ligands 60
Water 38
B-factors
Protein 55.7
Ligand/ion 53.7
Water 49.6
Rmsds
Bond lengths (A˚) 0.011
Bond angles () 1.490
Values in parentheses are for highest-resolution shell.
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Three-Dimensional Structure of CD1c Presenting MPMTherefore the overall structure of CD1c in complex with MPM
was reminiscent of other CD1 isoforms in the location and chem-
ical nature of their A0 and F0 pockets.
Structural Topology of the CD1c Binding Groove:
Unique Features
Unique to CD1c was the presence of a portal to the exterior
located underneath the a1 helix, called the D0 portal because
of its similarity in location to the D pocket in MHC class I mole-
cules. Two amino acid substitutions found only in CD1c (G26
and L74) are involved in the architecture of this portal, with
contributions from G28 (found in other CD1 isoforms) (Figure 4A,
top; Figure S1). In CD1b, most closely related to CD1c based on
structural and amino acid homology, T26 and I74 closed off this
portal to the exterior, despite sharing the glycine at position 28
(Figure 4A, bottom; Figure S1). An additional opening was noted
in the CD1c structure, called the E0 portal, which connects the
F0 pocket to the exterior through a narrow tunnel under the a1
helix. This opening was formed by several amino acids that are
either unique to CD1c (F16, L77, and V96) or are shared with
other isoforms (F18, T78, I81) (Figure 4A, top; Figure S1). Key
to the formation of both portals was the increased distance
between the a1 helix and the S2 b strand of the a1 domain
b sheet, in part resulting from the presence of the large aromatic
side chain at position 16 (F16) (Figure 4B; Figure S1). This caused
a 2.5 A˚ increase in main chain-main chain distance between
the a1 helix and b sheet at the location of these portals
(Figure 4B).856 Immunity 33, 853–862, December 22, 2010 ª2010 Elsevier Inc.The most striking aspect of CD1c was the open nature of the
F0 pocket, here termed the F0 groove, a feature not found in other
CD1 molecules (Figure 5). CD1c’s F0 groove is open to solvent,
contrasting with the closed nature of the F0 pockets of other
CD1 isoforms. This open groove was created by both smaller
side chains in CD1c at positions 84, 140, and 144 (H, L, and V
in contrast to F, R, and F in CD1b) that failed to reach across
the a1 and a2 helical divide, and the extended conformation
of the connecting loop between the a1 helix and the S1 strand
of the a2 domain b sheet (Figure 5; Figure S1). In all other CD1
molecules this loop is tucked back into the architecture of the
F0 pocket, closing off this region to solvent (Figure 5; Figure S1).
The residues lining the F0 groove in CD1c were almost entirely
hydrophobic in nature; of the 21 side chain residues contributing
to this surface, only H84 is potentially charged (this side chain
was also disordered in the electron density) whereas the
remainder were composed of 8 aromatic and 12 nonpolar
residues (V, L, or I). Therefore, ligands bound in this groove
would preferentially be hydrophobic and/or aromatic in nature.
It was also notable that the atomic displacement factors (or B
factors) were highest in the a-helical regions of the F0 groove (Fig-
ure S2), suggestive of a higher intrinsic disorder or flexibility to
this region. This putative flexibility may be a contributing factor
to CD1c’s ability to accommodate alternative ligands in this
groove, such as the lipopeptide ligands containing larger
peptide fragments.
Figure 3. Comparison of Antigen-Binding Cavities
of Human CD1 Isoforms in Complex with Ligands
Top and side views of the binding cavities of CD1c (light
magenta) with MPM and C12, CD1a (yellow) with myco-
bactin (1XZ0), CD1b (cyan) with GM2 and spacer lipids
(1GZQ), and CD1d (light purple) with a-galactosylcera-
mide (1ZT4), shown as surface cavity representations.
Red, blue, and yellow surface colors represent the contri-
bution of oxygen, nitrogen, and sulfur atoms to the surface
cavity, whereas ligands are colored with the following
atom designations: carbon, yellow; oxygen, red; nitrogen,
blue; phosphorus, orange. Residues forming conserved
features in CD1c are shown as sticks and colored as
described above. Cavity volumes for each CD1 isoform
were calculated with Pocket Finder (Hendlich et al.,
1997) and are indicated in A˚3.
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Three-Dimensional Structure of CD1c Presenting MPMMannosyl-b1-Phosphomycoketide Presentation
by CD1c
Liquid chromatography-mass spectrometry (LC-MS) of our
CD1c loaded with MPM showed a significant enrichment of
MPM, confirming that MPM was bound in our purified complex
(Figure S3). The LC-MS analysis also revealed bound hydro-
carbon chains ranging in length from C8 to C18 (Figure S3).
Omit map electron density showed a clear clockwise traverse
of the methylated hydrocarbon chain of MPM through the A0
pocket, exiting through the D0 portal (Figures 2 and 4A).
The C32 MPM (equivalent to the natural M. tuberculosis MPM)
lipid tail was accommodated perfectly in the A0 pocket, demon-
strating that the optimal length of hydrocarbon chains for CD1c is
approximately 27 carbons (the remaining 5 are methyl groups).
The exact placement of the phosphomannose head group was
unclear in initial rounds of refinement, so we used molecular
dynamics simulations and energy minimization based on omit
map density to estimate the optimal positioning of the MPM lipid
ligand within the A0 pocket. Two positions were determined to be
most probably based on these simulations: one, designated A1,Immunity 33, 853–features optimal hydration and placement of the
negatively charged phosphate group; the
second, designated A2, was positioned accord-
ing to electron density that extends out of the D0
portal, positioning the head group lower in the A0
portal in a less optimal hydrophobic environ-
ment (Figure S4). Further rounds of refinement
with the lipid in the A1 position revealed omit
map density for two water molecules consistent
with a water-mediated stabilization of the head
group (Figure 6). Five highly probable hydrogen
bonds (distance < 3.3 A˚, Table S1) coordinating
the phosphomannose head group were evident
and shown in Figure 6 as large dashes, four of
which are water mediated. The fifth hydrogen
bond was between the main chain carbonyl of
F72 and the ring oxygen of the mannose. Addi-
tional potential hydrogen bonds were present
(Figure 6 and Table S1; some, but not all, of
these weak hydrogen bonds are indicated as
small dashes), indicating that positioning of the
phosphomannose head group in A1 wasoptimal in regards to both our electron density data and molec-
ular dynamics simulations.
Density in the F0 groove of our CD1c structure was consistent
with a C12 hydrocarbon chain, supported by our LC-MS analysis
of lipids bound to CD1c. This LC-MS data showed that CD1c
could also bind free fatty acids (FFAs) ranging from C8 to C18,
with enrichment in C12 (Figure S3B). However, the presence of
other hydrocarbon chains from these FFAs made it unclear
whether the density in the structure represented a C12 hydro-
carbon chain, an average of a population of variable hydro-
carbon chain lengths (similar to the averaged density present
in the first ‘‘unloaded’’ CD1 structure of murine CD1d [Zeng
et al., 1997]), and/or an alternatively placed MPM. Therefore
we have conservatively placed a C12 hydrocarbon chain in the
density to represent these possibilities. Molecular dynamics
simulations suggested that a portion of MPM lipid tail could be
stably bound in the F0 groove (Figure S4). However, the lack of
sufficient electron density for the MPM lipid tail in the F0 groove
suggested that the most stable conformation for MPM is in the
A0 pocket, as observed (Figures 2 and 3).862, December 22, 2010 ª2010 Elsevier Inc. 857
Figure 4. Unique Features in CD1c: D0 and E0 Portals
(A) Ribbon (left) and surface (right) diagram of the D0 and E0 portals in CD1c
(magenta) and their comparison to CD1b (cyan). Residues forming the D0
and E0 portals in CD1c and corresponding residues in CD1b are shown in
yellow and orange, respectively.
(B) Overlay of ribbon diagrams of CD1c andCD1b reveal an increased distance
between the a1 helix and the S1 strand of the a2 b sheet in CD1c. The
distances are shown as yellow dashes and the increase is indicated at three
positions corresponding to the location of the D0 and E0 portals in CD1c.
Figure 5. Residues and Features Forming the F0 Groove in CD1c and
Comparison to CD1b
Top view of a surface representation (left) and ribbon diagram (right) of CD1c
(magenta, top) and CD1b (cyan, bottom). Residues lining the F0 groove in CD1c
are shown in light pink and the corresponding residues in CD1b are shown in
teal. The unresolved residues in the flexible loop connecting the CD1c a1 helix
to the b sheet are shown as a dashed line.
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The unique F0 groove structure led us to speculate that this
feature may allow CD1c to bind diverse antigens for presentation
to T cells. Because previous work has demonstrated a clear role
for CD1c in lipopeptide presentation through characterization of
a stimulatory 12-mer lipopeptide similar in sequence to the
myristoylated NEF (Van Rhijn et al., 2009), we sought to test
whether the F0 groove played a role in binding of the peptide
portion of this antigen. The defined sequence of the peptide
motif, GGKWSKXSKWSK with acylation at the N-terminal
glycine, contained two tryptophan residues and a kynurenine
(designated as ‘‘X’’), an oxidized form of tryptophan. Titration
of this synthetic lipopeptide into a solution containing CD1c
resulted in clear quenching of tryptophan fluorescence (Figure 7).
Based on these titration data, the equilibrium binding constant
(KD) of this lipopeptide for CD1c was calculated to be 66 nM.
We therefore propose a model whereby the peptide moiety is
associated with the F0 groove (either buried or associated with
its surface) of CD1c while the acyl chain is accommodated in
the A0 pocket, similar to what we observe for MPM.Figure 6. Hydrogen Bonding Network between CD1c and MPM
CD1c is shown as a ribbon diagram with residues involved in hydrogen
bonding with MPM shown as sticks and labeled. Atoms are colored as such:
yellow, carbon; blue, nitrogen; red, oxygen; orange, phosphorus. Two bound
water molecules are shown as purple spheres. Highly probable hydrogen
bonds are displayed as large dashes, potential ones as small dashes.DISCUSSION
CD1 molecules, although nonpolymorphic, have evolved
specific structural features enabling them to bind and present
unique repertoires of lipid-based ligands to T cells. All structural
information to date suggests a model whereby CD1 molecules858 Immunity 33, 853–862, December 22, 2010 ª2010 Elsevier Inc.anchor their antigens through binding of their alkyl chains in
pockets or tunnels, positioning the polar lipid head groups in
their A0 or F0 portals, accessible to recognition by a T cell
receptor. The size and complexity of these pockets dictates
the lipid-based antigens that can be bound by each isoform.
CD1a possesses a ‘‘molecular ruler’’ in the form of a restricted
sized A0 pocket, limiting bound alkyl chains to a particular length.
The F0 pocket of CD1a, however, can accommodate both the
N-aryl branch of a siderophore lipopeptide (Zajonc et al.,
2005b) or the fatty acid chain of a sulfatide (Zajonc et al.,
2003). On the other hand, CD1b has evolved a connected
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Figure 7. Analysis of Lipopeptide Binding to CD1c with Fluores-
cence Spectroscopy
A fixed concentration of CD1c was incubated with increasing concentrations
of lipo-12, and the tryptophan fluorescence signal of the samples was
measured. The quenching of tryptophan fluorescence with increasing
amounts of lipo-12 was expressed as a ratio (E Eo)/Eo, the change in fluores-
cence divided by the control fluorescence in the absence of added lipo-12.
The data were fit to a one-site binding model to determine the apparent KD
of this interaction.
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Three-Dimensional Structure of CD1c Presenting MPMnetwork of A0, F0, C0, and T0 channels (Gadola et al., 2002),
creating a ‘‘maze’’ that has the capacity to fit alkyl chains up to
C80 in length. A unique C
0 portal also allows variation in size of
the bound lipid moiety, acting as an escape hatch for lipids of
varying length. Mouse and human CD1d appear well suited
to bind diacylated lipids (Koch et al., 2005; Wu et al., 2006;
Zajonc et al., 2005a, 2005c, 2008; Zeng et al., 1997) such as
the canonical a-galactosylceramide (a-GalCer), a potent agonist
for the CD1d-restricted invariant natural killer T cell population.
The acyl chain of CD1d-bound lipids is bound in the A0 pocket
whereas the sphingosine or phytosphingosine chains are found
in the F0 pocket. We have shown here that CD1c, the last of
the lipid-presenting human isoforms to be structurally character-
ized, has structural features unlike those present in the other
human CD1 isoforms. These features endow CD1c with the
unique ability to present divergent antigens such as the
branched mycoketide, MPM, from M. tuberculosis and lipopep-
tides with long peptide moieties.
In our structure, MPM appears bound exclusively in the A0
pocket, exiting through the D0 portal underneath the a1 helix. It
is this portal, unique to CD1c, that appears to allow the preferen-
tial binding of the branched alkyl chain of MPM, and enables the
observed variation in length (C30–C34) of MPM that can activate
T cells when presented in CD1c (de Jong et al., 2007). Similar to
other complexes of CD1molecules with lipids, this bindingmode
situates the polar phosphomannose head group ideally for
recognition by a T cell receptor. The electron density of MPM
in our structure was consistent with two alternative conforma-
tions; molecular dynamics simulations with energy minimization
favored the A1 conformation consistent with optimal solvation
and hydrogen bonding of the phosphomannose head group.
However, the electron density for the alkyl chain extended out
the D0 portal, suggesting that the computationally less preferred
A2 conformation may also exist in our structure.
Our structure also provides a rationale for CD1c’s specificity
for MPM’s lipid length and stereochemistry of methylation.ILonger length mannosyl-b1-phosphodolichol (MPD) analogs of
the length C55-95 are essentially nonstimulatory to CD1c-reactive
T cells (Moody et al., 2000); alkyl chains of this length would have
to extend either out of the D0 portal or out of the A0 portal into
solvent, both highly energetically unfavorable conformations
and therefore not preferred for binding into CD1c. Furthermore,
because of the constriction in the circular A0 pocket, it is unlikely
that longer branched alkyl chains could wrap around this pocket
in the fashion seen in CD1b (Gadola et al., 2002). Our structure
also reveals why the natural, all-S conformation of M. tubercu-
losis C32 MPM is preferred over synthetic, stereorandom C30
MPM, which produces a 20- to 40-fold decrease in stimulation
of the CD8-1 T cell clone that recognizes the complex of CD1c
withMPM (de Jong et al., 2007). Based on the turn that is present
in the all-S C32 MPM in our structure, alternative positioning of
the last four methyl groups of MPM would force them to point
inward in the turn, clashing with the natural turn of the A0 pocket.
The all-S form has these last four methyl groups splayed to the
outside of the turn, allowing for a tighter bend to the alkyl chain.
Because 1/16th (24) of the stereorandom MPM mixture would
be composed of all-S methyl groups in these positions, this
would explain the decrease, yet not abolition, of the T cell stim-
ulation activity of this mixture.
We and others have shown that CD1c can also bind diacylated
lipids similar to those found in other CD1 isoforms (Gilleron et al.,
2004; Guiard et al., 2009; Shamshiev et al., 2002), so it is likely
that CD1c can stably bind two alkyl chains in its A0 and F0
pockets. However, accommodation of a single alkyl chain such
as that seen in MPM probably requires the presence of the
methyl branches to stabilize it in the CD1c A0 pocket. Removal
of these methyl branches results in a drastic decrease in T cell
simulation (de Jong et al., 2007), probably because of the weak-
ened stability of these MPM variants in CD1c. The electron
density apparent in the F0 groove of CD1c suggests that this
structure, although open to solvent, maintains the ability to
bind alkyl chains. Indeed, a variety of free fatty acids, enriched
in the hydrocarbon chain C12, were characterized by LC-MS
from our MPM-loaded CD1c. Furthermore, molecular dynamics
simulations suggest that MPM can also be bound in the F0
groove, although our structure suggests that it is not accommo-
dated with the same occupancy or stability as that seen in the A0
pocket. Thus, the electron density we see is probably due to
averaging over the various lipid species that may be bound in
the F0 groove.
The presence of the F0 groove provides a compelling explana-
tion for how CD1c can bind, at high affinity, divergent ligands
such as the dodecameric lipopeptide (lipo-12) that mimics
myristoylated proteins (Van Rhijn et al., 2009). Myristoylation is
the process by which myristate (saturated C14) is covalently
attached via an acyl linkage to an N-terminal glycine residue.
Vital to eukaryotic cellular processes and required for the
functioning of certain viral proteins (such as the myristoylated
Nef [Guy et al., 1987] and Gag [Veronese et al., 1988] proteins
of the human immunodeficiency virus [HIV]), myristolation is pre-
dicted to occur on 0.8% of mammalian proteins and 3.7% of
viral proteins (http://mendel.imp.ac.at/myristate/myrbase/). The
affinity calculated for lipo-12 (66 nM) is similar in magnitude
to that of lipoarabinomannan (LAM) for CD1b (32–53 nM) (Ernst
et al., 1998) and to those measured for high-affinity peptidesmmunity 33, 853–862, December 22, 2010 ª2010 Elsevier Inc. 859
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for CD1d and aGalCer (ranging from 340 nM [Naidenko et al.,
1999] to 1–10 mM [Cantu et al., 2003]). It is important to note
that in all cases, these are relative measurements because
CD1 molecules are probably loaded with endogenous lipids
during eukaryotic synthesis or detergent molecules during
refolding. In addition, lipids most probably exist in a micellar
form depending on their critical micellar concentration (CMC).
Therefore these measurements reflect a combination of param-
eters, including removal of lipids from the micellar state and
competition with CD1-bound lipid. However, our affinity
measurements for lipo-12 and CD1c suggest involvement of
the peptidic portion of the antigen, considering that unbranched,
saturated synthetic versions of MPM are not stimulatory and
therefore unlikely to be stably bound (de Jong et al., 2007).
Supported by our tryptophan fluorescence quenching results
and affinity determination, we propose a model where the
acyl chain of lipo-12 is bound in the A0 pocket, similar to the
branched alkyl chain of MPM, whereas the peptide portion,
anchored by the two tryptophans and one kynurenine, is bound
in the F0 groove. It is important to note, however, that tryptophan
fluorescence quenching can be caused by a variety of factors
including small structural changes in the protein and therefore
does not provide direct evidence of the peptide portion
being bound in the F0 groove. In the absence of a crystal struc-
ture of the complex of CD1c and lipo12, other models are also
plausible, such as the peptide portion associating with the
surface of CD1c, outside of the F0 groove. Shorter lipopeptides,
or alteration of the amino acid sequence of the peptide portion,
can affect T cell reactivity (Van Rhijn et al., 2009); however,
it awaits further analysis to determine whether alteration of
these residues affects lipopeptide loading and stability in
CD1c. This model of lipopeptide presentation by CD1c provides
insight into how acylated proteins can be recognized as
pathogenic patterns, raising questions about howCD1c-reactive
T cells may discriminate between endogenous and foreign
lipopeptides.
EXPERIMENTAL PROCEDURES
Synthesis of Mannosyl-b1-Phosphomycoketide
The synthesis of mannosyl-b1-phosphomycoketide (or b-D-mannosyl phos-
phomycoketide) (MPM) (structure #29) is outlined in Supplemental Experi-
mental Procedures, Schemes S1–S5. Starting from commercially available
methyl (2S)-3-hydroxy-2-methylpropionate (1), compounds 11 (Scheme S1),
17 (Scheme S2), and 22 (Scheme S3) were prepared. With a sequence of
reactions that included Julia-Kocienski coupling, platinum- and palladium-
catalyzed hydrogenations, and the Dess-Martin oxidation, these fragments
were connected synthetically (Scheme S4) in good yield to give the precursor
mycoketide C7 (n-heptyl at the tail end of the lipid). The synthesized mycoke-
tide was used to prepare mannosyl-b1-phosphomycoketide 29 according to
a literature procedure (Scheme S5) (van Summeren et al., 2006). The mass
spectrum and other analytical data confirmed the structure of 29. Negative
ion MS Calcd for C38H79O9P
 (M-Na+): 707.5, found: 707.4. Synthetic details
will be reported elsewhere.
Protein Expression, Purification, and Crystallization
The CD1copt construct was subcloned into the baculovirus transfer vector
pAcGP67A (BD Biosciences) with a deca-His tag and expressed in High Five
cells with the baculovirus expression system (Saphire Baculovirus DNA-Orbi-
gen). The protein was purified with Ni-NTA resin, eluted with buffer containing
200mM imidazole, and treated with carboxypeptidase A (Sigma) at 25Cover-860 Immunity 33, 853–862, December 22, 2010 ª2010 Elsevier Inc.night to remove the C-terminal His-tag. The protein was further purified by
gel filtration via a Superdex 200 column (GE Healthcare) equilibrated with
HEPES Buffered Saline (HBS: 10 mM HEPES [pH 7.2], 150 mM NaCl, 0.02%
azide).
To loadMPM into CD1c, 0.2mg ofMPMper 1mg of CD1cwere incubated at
37C for 30 min in HBS containing 0.05% Tween 20. The CD1c-MPM complex
was repurified by gel filtration with a Superdex 200 column equilibrated in HBS
containing 50 mM NaCl to remove excess lipid and detergent. For crystalliza-
tion, peak fractions were pooled and concentrated to 10 mg/mL. Crystalliza-
tion screens were carried out with the sitting drop method and initial hits
were optimized in both sitting and hanging drops by varying pH, precipitant
concentration, and the use of additives. The best crystals were obtained via
a hanging-drop setup at 18C by combining 1 ml protein solution and 1 ml
mother liquor containing 1.05 M sodium citrate, 100 mM CHES (pH 9.4), and
25 mM triglycine.
Data Collection and Processing
X-ray data sets were measured on a MAR300 CCD at beamline 23 ID-D at the
Advanced Photon Source (APS) at Argonne National Laboratory. Crystals were
cryoprotected with 50% sodium malonate before cooling to 100K.
A complete 2.5 A˚ data set was collected with 1 oscillations over 150 frames
and a 1.033 3 1010 m wavelength. The crystals indexed in space group
P212121 with unit cell dimensions a = 53.72 A˚, b = 87.09 A˚, c = 88.81 A˚.
HKL2000 was used to index, integrate, and scale the data (Otwinowski and
Minor, 1997). Data statistics are shown in Table 1.
Structure Determination and Analysis
We used a CD1b heavy chain and b2m (Garcia-Alles et al., 2006) as a search
model, and stepwise molecular replacement with Phaser (McCoy et al.,
2007) located the single CD1c molecule per asymmetric unit. Rigid body
refinement was performed with Phenix (Adams et al., 2010), followed by
manual building via Coot (Emsley and Cowtan, 2004) and individual site
and B-factor refinement with Phenix (Adams et al., 2010). The stereochem-
istry of the model was improved via a backbone optimization procedure
incorporating a torsional statistical potential contingent on amino acid type,
its secondary structure, as well as the identity of its two neighbors (DeBartolo
et al., 2009), followed by real space refinement with a two-step algorithm
developed by E.J.H., K.F. Freed, and T.R. Sosnick (unpublished data).
Both composite (Phenix [Adams et al., 2010]) and simple (CCP4 Sfcheck
[CCP4, 1994]) omit maps were calculated at each stage to locate density
for ligands that were not present in the model. Hydrogen bonding contacts
between MPM and CD1c were calculated with the program Contacts
(CCP4 program package [CCP4, 1994]). Main chain rmsd values between
CD1c and CD1a, CD1b, and CD1d were calculated with PDBeFold
(protein structure comparison service SSM at European Bioinformatics Insti-
tute [http://www.ebi.ac.uk/msd-srv/ssm], authored by E. Krissinel and
K. Henrick). Total ligand binding groove volumes of CD1a, CD1b, CD1c,
and CD1d were computed with Pocket-Finder (an algorithm based on Ligsite
[Hendlich et al., 1997]). All structural figures were generated with the program
Pymol (DeLano Scientific).
Analysis of Lipopeptide Binding with Fluorescence Spectroscopy
To measure binding of lipo-12 to CD1c, 1 ml samples containing 10 nM CD1c
in HBS and various concentrations of lipo-12 ranging from 5 nM to 10 mMwere
incubated at 37C for 1 hr. Tryptophan fluorescence of the sample was
measured with a PTI fluorimeter (model 810) with an excitation wavelength
of 280 nm, and the maximum emission signal at 340 nm was observed. The
quenching of tryptophan fluorescence with increasing amounts of lipo-12
was expressed as a ratio (E  Eo)/Eo, the change in fluorescence divided by
the control fluorescence in the absence of added lipo-12. The signal ratio
was plotted against lipo-12 concentration and fit via nonlinear regression in
GraphPad Prism to a one-site binding model.
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Coordinates and structure factors for the complex of CD1c with MPM have
been deposited in the Protein Data Bank under the accession code 3OV6.
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